See also this year's filing and all EDGAR filings for this company.
PDF Report 0000316253_2020_ENZO_Biochem_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0000316253')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000316253, ENZO Biochem INC
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 8,484,000 |
| 1 | AssetsNonCurrent | 2,449,000 |
| 2 | AssetsCurrent | 81,453,000 |
| 3 | PropertyPlantAndEquipment | 14,254,000 |
| 4 | remainder_Assets | 0 |
| 5 | LongTermLiabilities | 4,603,000 |
| 6 | LiabilitiesCurrent | 16,009,000 |
| 7 | remainder_Liabilities | 0 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 57,922,000 |
| 10 | GeneralAndAdministrativeExpense | 44,265,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 0 |
| 15 | ResearchAndDevelopmentExpense | 3,175,000 |
| 16 | remainder_Expenses | -25,925,000 |
| 17 | remainder_Revenues | 81,170,000 |
| 18 | remainder_NetIncome | 756,000 |
| 19 | remainder_ComprehensiveNetIncome | 480,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 106,640,000 |
| 1 | Liabilities | 20,612,000 |
| 2 | Expenses | 79,437,000 |
| 3 | Revenues | 81,170,000 |
| 4 | StockholdersEquity | 86,028,000 |
| 5 | NetIncome | 2,489,000 |
| 6 | ComprehensiveNetIncome | 2,969,000 |
| 7 | BaseVar | 144,547,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.01 |
| 9 | EconomicCapitalRatio | 2.39 |
Edgar->Model Mapping
Feature Distribution
Change over Time
